NCT00078494 2008-03-04
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
1 trialsCompleted × Nasopharyngeal Neoplasms × EBV-associated membrane antigen, Epstein-Barr virus × Clear all